Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Assets (2023 - 2025)

Historic Assets for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $330.0 million.

  • Beta Bionics' Assets changed N/A to $330.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.0 million, marking a year-over-year change of. This contributed to the annual value of $149.6 million for FY2024, which is 3599.15% up from last year.
  • Beta Bionics' Assets amounted to $330.0 million in Q3 2025.
  • Beta Bionics' Assets' 5-year high stood at $338.0 million during Q1 2025, with a 5-year trough of $110.0 million in Q4 2023.
  • Moreover, its 3-year median value for Assets was $330.0 million (2025), whereas its average is $251.5 million.
  • Within the past 5 years, the most significant YoY rise in Beta Bionics' Assets was 3599.15% (2024), while the steepest drop was 3599.15% (2024).
  • Beta Bionics' Assets (Quarter) stood at $110.0 million in 2023, then skyrocketed by 35.99% to $149.6 million in 2024, then surged by 120.55% to $330.0 million in 2025.
  • Its Assets was $330.0 million in Q3 2025, compared to $330.0 million in Q2 2025 and $338.0 million in Q1 2025.